✦ LIBER ✦

A critical review of women's sleep–wake patterns in the context of neo-/adjuvant chemotherapy for early-stage breast cancer

✍ Scribed by Grigorios Kotronoulas; Yvonne Wengström; Nora Kearney

Book ID: 113507570
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 393 KB
Volume: 21
Category: Article
ISSN: 0960-9776
DOI: 10.1016/j.breast.2011.12.004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of obesity on toxicity in women t

Effect of obesity on toxicity in women treated with adjuvant chemotherapy for early-stage breast cancer: a systematic review

✍ James Carroll, Melinda Protani, Euan Walpole, Jennifer H. Martin 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 227 KB

121. Evaluating patterns of cytokine exp

121. Evaluating patterns of cytokine expression in women undergoing chemotherapy for early-stage breast cancer: A factor analytic approach

✍ K.E. Stewart; R. Elswick; D.E. Lyon; N.L. McCain 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 38 KB

Patients' preferences for adjuvant chemo

Patients' preferences for adjuvant chemotherapy in early breast cancer: a review of what makes it worthwhile?

✍ Vlatka Duric; Martin Stockler 📂 Article 📅 2001 🏛 The Lancet 🌐 English ⚖ 300 KB

PCN72 GENE EXPRESSION PROFILING FOR GUID

PCN72 GENE EXPRESSION PROFILING FOR GUIDING ADJUVANT CHEMOTHERAPY DECISIONS IN WOMEN WITH EARLY BREAST CANCER: A COST-EFFECTIVENESS ANALYSIS OF 1000 STRATEGIES FOR THE PROVISION OF ADJUVANT! ONLINE, ONCOTYPE DX AND CHEMOTHERAPY

✍ M. Paulden; J. Franek; B. Pham; M. Krahn 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

Estimation of the incidence of febrile n

Estimation of the incidence of febrile neutropenia in women receiving docetaxel plus cyclophosphamide as adjuvant therapy for early-stage breast cancer: a large community-based retrospective study

✍ Rodolfo Eduardo Bordoni; Sally Taylor Haislip; James Walter Gilmore Jr; Joyce Sh 📂 Article 📅 2012 🏛 Frontline Medical Communications, Inc. 🌐 English ⚖ 236 KB

Anastrozole is safer and may be more eff

Anastrozole is safer and may be more effective than tamoxifen in postmenopausal women with early-stage breast cancer: Abstracted from: Baum M, Buzdar A, Cuzick J, et al. The ATAC (Arimidex, Tamoxifen Alone or in Combination) Trialists' Group. Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer. Cancer 2003;98:1802–10

✍ Hetty Carraway; Antonio C. Wolff 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 151 KB